arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

LifeMD, Inc.

LFMD
$2.29 ▼ -0.16 (-6.53%) at close
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
59 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Moderately Bullish
auto_awesome

Analytical Summary

LifeMD, Inc. demonstrates solid fundamentals with strength in Return on Common Equity (%). Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $109.4M
Dividend Yield —
Revenue Growth -24.0% →
Op. Margin -15.1% ↗
ROIC -70.7% ↘
FCF / Share $-0.15 ↘
Trailing P/E —
Price / Book 13.8x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

59-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$47.28M
↓ -24.0% —
Net Income Profit after all expenses
$-7.08M
↓ -241.4% —
Operating Margin Operating profit as % of sales
-15.1%
↑ +15.3% 21th
FCF / Share Free cash flow per share
$-0.15
↓ -2140.8% —
Long-Term Debt Long-term obligations
$15.90M
↑ +47.0% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
38
Returns
98
Financial Health ↑
35
Cash Quality ↓
38

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 15 years · 59 quarters